Sjogren’s syndrome is an inflammatory disorder characterized by lymphocytic infiltrates in exocrine organs, primarily in lacrimal and salivary glands, resulting in classic sicca symptoms of dry mouth (xerostomia) and dry eyes (xerophthalmia). Etiology of the disorder is unknown though finding suggests interaction between innate immunity and acquired immunity may lead to develop Sjogren’s syndrome. Worldwide, it affects one to two million people. In the U.S. Sjogren’s syndrome is the second ... Read more
Sjogren's syndrome is an autoimmune disease that causes dryness in the mouth and eyes due to lack of tears and saliva. The prevalence of this syndrome is increasing with rising environmental pollution and other factors. This has increased the demand for medications managing dry eyes and mouth, tear and saliva substitutes, and devices monitoring dryness levels associated with Sjogren’s syndrome.
Sjogren's syndrome therapeutics comprise biologics, immunosuppressants, and other drugs that are used for the treatment of dry eyes and mouth caused by Sjogren's syndrome. Sjogren's syndrome is an autoimmune condition that causes chronic inflammation and dryness in the tear and saliva glands. The increasing prevalence of autoimmune diseases and the rising geriatric population are key factors fueling the demand for Sjogren's syndrome therapeutics. Sjogren's syndrome is commonly associated ... Read more
